Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lens biomaterials for cataract surgery].

T Amzallag1, J Pynson

  • 1Institut Ophtalmique, Somain.

Journal Francais D'Ophtalmologie
|September 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Acute cataract and surgical complication in a type 1 diabetic].

Journal francais d'ophtalmologie·2017
Same author

[Prevalence and causes of pain after cataract surgery: Comparison of 1st and 2nd eyes].

Journal francais d'ophtalmologie·2017
Same author

[The alpha: a risk factor for failure of cataract surgery?].

Journal francais d'ophtalmologie·2014
Same author

Aircrew fitness decisions and advances in refractive surgery techniques.

German journal of ophthalmology·1993
Same author

[Progressive cone dystrophy: electrophysiological changes in female carriers].

Journal francais d'ophtalmologie·1990
Same author

[Leber's idiopathic stellate macula: apropos of 3 cases].

Bulletin des societes d'ophtalmologie de France·1989
Same journal

Silent threat to sight after bariatric surgery: Vision loss from vitamin A deficiency.

Journal francais d'ophtalmologie·2026
Same journal

Persistent subretinal fluid and subretinal precipitates following pneumatic retinopexy.

Journal francais d'ophtalmologie·2026
Same journal

Real-time documentation of acute pre-retinal hemorrhage in central retinal vein occlusion.

Journal francais d'ophtalmologie·2026
Same journal

Incidental detection of benign lobular inner nuclear layer proliferations (BLIPs) in a young adult.

Journal francais d'ophtalmologie·2026
Same journal

Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

Journal francais d'ophtalmologie·2026
Same journal

[Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

Journal francais d'ophtalmologie·2026
See all related articles

The development of intraocular lenses (IOLs) has seen limited biomaterial innovation since rigid poly-methyl-methacrylate (PMMA) lenses were first used. Current choices like acrylic polymers and silicone elastomers prioritize clinical performance alongside biocompatibility.

Area of Science:

  • Ophthalmology
  • Biomaterials Science
  • Polymer Chemistry

Context:

  • The first intraocular lenses (IOLs) utilized rigid poly-methyl-methacrylate (PMMA).
  • Phacoemulsification in the 1970s enabled smaller incisions and material diversification.
  • Despite advancements, the range of IOL biomaterials remains limited to acrylic polymers and silicone elastomers.

Purpose:

  • To review the historical progression and current limitations of biomaterials used in intraocular lens (IOL) technology.
  • To highlight the evolving criteria for biomaterial selection in IOLs, moving beyond simple in vivo tolerance.
  • To emphasize the importance of material properties in conjunction with IOL design for optimal clinical outcomes.

Summary:

  • Intraocular lens (IOL) biomaterial selection has evolved from early poly-methyl-methacrylate (PMMA) to current acrylic and silicone options.

Related Experiment Videos

  • Biomaterial choice now critically depends on clinical performance factors such as injectability, optical quality, and long-term intraocular behavior.
  • Physical and chemical characteristics of biomaterials, alongside IOL design, are key to selecting the best lens.

    • Impact:

    • Informs the selection of advanced biomaterials for next-generation intraocular lenses.
    • Contributes to improved patient outcomes through enhanced IOL performance and biocompatibility.
    • Guides future research and development in ophthalmic biomaterials for refractive surgery.